The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Firms / A••••• B•• M••••••••• C••••••• L••

A••••• B•• M••••••••• C••••••• L••

Institutional venture firmOakland, CAa••••••••.comSEC venture capital fund adviser

A••••• Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.

venture manager, reported GAV $358M across 3 vehicles

Importance
25
moderate
Active deployment
8
low
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
6
low
Identity and regulatory footprint
Headquarters
Oakland, CAadviserinfo.sec.gov
Office address
1111 BROADWAY, SUITE 1300, Oakland, CA, 94607-4091adviserinfo.sec.gov
Business phone
510-227-2102adviserinfo.sec.gov
Website
a••••••••.com
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 31, 2026
Private funds reported
3 (3 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$773Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
T••••••••• I••• (Managing Director Of A••••• Bio Gp 1, Llc), NA
business phone
510-227-2102adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
Sectors
biotech
Stages
not stated or not yet read
Geography
united states
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 2
Funds and vehicles
3 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
A••••• B•• F••• 2• L•••Fund2022 adv first reportedActive deployment$196M
Dec 21, 2024
108$0
of $250M
Jul 14, 2021
A••••• B•• F••• 1• L•••Fund2019 form d first saleMature$162M
Dec 21, 2024
229$133M
of $133M
Oct 23, 2020
A••••• B•• F••• 3• L•••FundunknownUnknownunknownunknown$0
of $400M
May 31, 2024
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
5 current, 1 departed
M••• F••••••
Co-Founder And Chairman Of The Scientific Advisory Board · since Jul 1, 2019
Founder or executive
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
C•••• K•••
Managing Director Of A••••• Bio Gp 2, Llc · since Aug 1, 2022
General partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
P••• J•• S•••••
Managing Director Of A••••• Bio Gp 1, Llc · since Jul 1, 2019
General partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
P••••••• K••••••
Managing Director Of A••••• Bio Gp 2, Llc · since Jul 1, 2021
General partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
J••••• J••••••
Managing Director · since Jul 1, 2019
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
1 departed (kept with end dates)
Investments on record
2 edges, 2 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
K••••• B••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
O•••••• B••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
7 dated events
  1. Mar 28, 2024
    I••• D•••• Z••••• (Managing Director Of A••••• Bio Gp 2, Llc) no longer on Schedule A of A••••• B•• M••••••••• C••••••• L••
    Person leftPeopleInferenceI••• D•••• Z•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Aug 1, 2022
    C•••• K••• joined Schedule A of A••••• B•• M••••••••• C••••••• L•• as Managing Director Of A••••• Bio Gp 2, Llc
    Person joinedPeopleFactC•••• K•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Mar 31, 2022
    A••••• B•• F••• 2• L••• first reported on Form ADV by A••••• B•• M••••••••• C••••••• L•• (Venture Capital Fund), GAV $202,979,965
    Fund first reported on Form ADVFundsFactA••••• B•• F••• 2• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Jul 1, 2021
    I••• D•••• Z••••• joined Schedule A of A••••• B•• M••••••••• C••••••• L•• as Managing Director Of A••••• Bio Gp 2, Llc
    Person joinedPeopleFactI••• D•••• Z•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Jul 1, 2021
    P••••••• K•••••• joined Schedule A of A••••• B•• M••••••••• C••••••• L•• as Managing Director Of A••••• Bio Gp 2, Llc
    Person joinedPeopleFactP••••••• K••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Sep 23, 2019
    A••••• B•• M••••••••• C••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Sep 23, 2019
    A••••• B•• F••• 1• L••• first reported on Form ADV by A••••• B•• M••••••••• C••••••• L•• (Venture Capital Fund), GAV $92,550,000
    Fund first reported on Form ADVFundsFactA••••• B•• F••• 1• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $358M across 3 vehicles
  2. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $358M across 2 vehicles
Evidence
48 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserDec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserDec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2019-09-23Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-31Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-12-21Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2019-09-23Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone510-227-2102Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone510-227-2102Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionA••••• Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.
“meta description”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionA••••• Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.
“meta description”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersOakland, CAMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersOakland, CADec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address1111 BROADWAY, SUITE 1300, Oakland, CA, 94607-4091Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address1111 BROADWAY, SUITE 1300, Oakland, CA, 94607-4091Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
“We’re taking biotech venture capital where it needs to go”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Self-described typeventure_capital
“We’re taking biotech venture capital where it needs to go”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formLimited Liability CompanyMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyDec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://a••••••••.com/
“2 entries read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://a••••••••.com/
“2 entries read”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported3Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported2Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$773MMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$358MDec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyunited states
“geography words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyunited states
“geography words on the home page”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
“sector words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
“sector words on the home page”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://a••••••••.com/
“0 name/title pairs read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://a••••••••.com/
“0 name/title pairs read”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported3Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported2Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://a••••••••.com/Dec 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleHome | A••••• Bio | Translating Science, Benefiting Patients
“title tag”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleHome | A••••• Bio | Translating Science, Benefiting Patients
“title tag”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)